Table 3.
Demographics of patients undergoing cardiac catherization
| Demographics | 2019 | 2020 | P-value |
|---|---|---|---|
| N = 3545 | N = 2034 | ||
| Male, n (%) | 1852/2826 (66) | 1105/1604 (69) | 0.0231 |
| Age, median (IQR) | 70 (60–79) | 70 (59–78) | 0.0522 |
| History of CAD, n (%) | 940/2034 (46) | 555/1178 (47) | 0.6221 |
| Diabetes mellitus, n (%) | 588/1923 (31) | 341/1212 (28) | 0.1451 |
| Hypertension, n (%) | 1391/1769 (79) | 891/1111 (80) | 0.3131 |
| Currently smoking, n (%) | 325/1641 (20) | 254/1102 (23) | 0.0411 |
| Chronic kidney disease, n (%) | 347/1766 (20) | 217/1106 (20) | 0.9851 |
| BMI, median (IQR) | 27 (24.6–31) | 27.2 (24.2–30.5) | 0.3212 |
| LV function, median (IQR) | 55 (45–60) | 55 (45–60) | 0.1882 |
| ACE-I / ARB, n (%) | 1124/1740 (65) | 753/1089 (69) | 0.0131 |
| ß-Blocker, n (%) | 1031/1740 (59) | 700/1089 (64) | 0.0081 |
| Diuretics, n (%) | 726/1739 (42) | 435/1089 (40) | 0.3431 |
Tests used: 1Pearson χ2-test; 2Wilcoxon test